TMEM219 and cancer: In addition, CHI3L1 binds to a receptor complex consisting of TMEM219 and CD44v3, activating pathways like AKT, MAPK (p42/p44), and β-catenin, thereby promoting tumorigenesis, particularly in cancer cells and cancer-associated fibroblasts [21,22,37,38].